UK markets close in 4 hours 39 minutes

Kymera Therapeutics, Inc. (KYMR)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
33.53-0.52 (-1.53%)
At close: 04:00PM EDT
33.53 0.00 (0.00%)
After hours: 04:01PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
79,413
78,592
46,826
72,832
34,034
-
Operating expenses
Research development
195,673
189,081
164,248
137,017
62,105
-
Selling general and administrative
56,850
55,041
43,834
36,345
18,233
-
Total operating expenses
252,523
244,122
208,082
173,362
80,338
-
Operating income or loss
-173,110
-165,530
-161,256
-100,530
-46,304
-
Interest expense
210
196
176
175
115
-
Income before tax
-154,591
-146,962
-154,808
-100,217
-45,593
-
Income from continuing operations
-154,591
-146,962
-154,808
-100,217
-45,593
-
Net income
-154,591
-146,962
-154,808
-100,217
-45,593
-
Net income available to common shareholders
-154,591
-146,962
-154,808
-100,217
-54,643
-
Basic EPS
-2.86
-
-2.87
-2.09
-3.15
-1.37
Diluted EPS
-2.86
-
-2.87
-2.09
-3.15
-1.37
Basic average shares
58,218
-
53,933
47,989
17,350
30,195
Diluted average shares
58,218
-
53,933
47,989
17,350
30,195